Senior Director, Immunology S&E – Late-Stage Deals

CSL Plasma Inc.; Zürich; Hybrid; CHF 280.000 - 420.000; Vollzeit

Zusammenfassung

CSL Behring seeks a Senior Director of Search & Evaluation to lead strategic sourcing and evaluation of late-stage external clinical assets in Immunology. This role requires deep clinical expertise and strong engagement with KOLs and investigators, and will shape portfolio strategy through high-impact partnerships and transactions.

The position is hybrid-based onsite (3 days per week) at our R&D hub sites in Zurich, MA, or Waltham, with global collaboration across regions.

Qualifikationen

• 15+ years in biopharma with clinical development, external innovation, or business development.
• Advanced degree required (MD, PhD, or equivalent).
• Deep clinical expertise in Immunology.
• Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks.
• Strong understanding of regulatory pathways, market access, and competitive standards of care.

Aufgaben

• Lead senior S&E efforts influencing TA strategy and portfolio planning.
• Lead proactive sourcing for Phase 2 to marketed assets aligned with TA strategy.
• Co-lead internal meetings focused on evaluating and prioritizing New Product Opportunities (NPOs).
• Engage extensively with external KOLs, investigators, and networks to validate asset potential.
• Maintain awareness of changing standards of care and competitive landscape to inform sourcing priorities.
• Drive cross-functional due diligence across clinical, regulatory, commercial, and market access assessments.
• Partner with BD and Regional Ecosystem Leads to advance opportunities through negotiation and deal close.
• Represent the TA externally at conferences and build pharma/clinc networks.

Kenntnisse

Biopharma leadership

Clinical development

External innovation

KOL engagement

Ausbildung

MD, PhD, or equivalent

Jobbeschreibung

CSL Behring seeks a Senior Director of Search & Evaluation to lead strategic sourcing and evaluation of late-stage external clinical assets in Immunology. This role requires deep clinical expertise and strong engagement with KOLs and investigators, and will shape portfolio strategy through high-impact partnerships and transactions.

The position is hybrid-based onsite (3 days per week) at our R&D hub sites in Zurich, MA, or Waltham, with global collaboration across regions.